arXiv:2605. 26833v2 Announce Type: replace-cross Abstract: Polymers underpin applications across energy, healthcare, and materials science, yet their vast chemical space makes systematic discovery challenging.
By Yasharth Yadav, Tze Kwang Gerald Er, Atsushi Goto, Kelin Xia
arXiv:2606. 20753v2 Announce Type: replace-cross Abstract: Polymeric materials underpin modern technologies spanning energy storage, microelectronics, healthcare and sustainable manufacturing.
By Chenyao Ma, Linda Zhang, Yuheng Chen, Wei Du, Shangwen Fang, Zihao Jiang, Chuanyu Liu, Xinyu Ma, Rui Su, Gang Wang, Muyao Yu, Dong Zhong, Jie Zhu, Weibo Gong, Huan Gu, Limin Li, Chen Shen, Rui Wu, Zhenghao Wu, Kan Xu, Min Zhou, Donglin He, Xiayun Huang, Shan Jiang, Pengfei Ou, Jiayu Peng, Yuwei Zhang, Jie Zhao, Di Zhang, Piao Ma, Zhenghao Li, Hao Li
arXiv:2608. 01431v1 Announce Type: cross Abstract: Polymer property prediction and inverse generative design targeting desired properties are two crucial tasks in machine learning-assisted polymer design.
By Charlie Pyle, Adarsh Gadari, C. Adrian Figg, Zhenquan Jia, Yaohang Li, Chunjiang Zhu
arXiv:2508. 02641v2 Announce Type: replace-cross Abstract: Molecular crystal structure prediction (CSP) is essential for applications in pharmaceuticals and organic electronics.
By Vahe Gharakhanyan, Yi Yang, Luis Barroso-Luque, Daniel S. Levine, Sushree Jagriti Sahoo, Brandon M. Wood, Kyle Michel, Muhammed Shuaibi, Gregory J. O. Beran, Viachaslau Bernat, Misko Dzamba, Xiang Fu, Meng Gao, Xingyu Liu, Benjamin K. Miller, Keian Noori, Lafe J. Purvis, Tingling Rao, Ammar Rizvi, Matt Uyttendaele, Andrew J. Ouderkirk, Chiara Daraio, C. Lawrence Zitnick, Arman Boromand, Noa Marom, Zachary W. Ulissi, Anuroop Sriram
Polymer property prediction and inverse generative design targeting desired properties are two crucial tasks in machine learning-assisted polymer design. While the former has received considerable attention, there have been limited methods developed for the latter.
arXiv:2607. 20550v1 Announce Type: cross Abstract: The traditional "one drug, one target" paradigm of structure-based drug design (SBDD) frequently proves inadequate for treating multifactorial diseases such as cancer and neurodegenerative disorders, owing to compensatory signaling pathways and the emergence of drug resistance.
By Tianming Han, Zhijie Pan, Wenchi Ge, Qi Zhao